198 related articles for article (PubMed ID: 2170407)
1. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
Nunez D; Randon J; Gandhi C; Siafaka-Kapadai A; Olson MS; Hanahan DJ
J Biol Chem; 1990 Oct; 265(30):18330-8. PubMed ID: 2170407
[TBL] [Abstract][Full Text] [Related]
2. Dual effects of oleic acid on Ca2+ mobilization and protein phosphorylation in human platelets in presence or absence of platelet activating factor.
Kimoto M; Javors MA; Ekholm J; Siafaka-Kapadai A; Hanahan DJ
Arch Biochem Biophys; 1992 Nov; 298(2):471-9. PubMed ID: 1384432
[TBL] [Abstract][Full Text] [Related]
3. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
Vickers JD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
Nunez D; Kumar R; Hanahan DJ
Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
[TBL] [Abstract][Full Text] [Related]
5. Platelet activity and phosphoinositide turnover increase with advancing age.
Bastyr EJ; Kadrofske MM; Vinik AI
Am J Med; 1990 Jun; 88(6):601-6. PubMed ID: 2161185
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-induced alterations in inositol phospholipid metabolism in human platelets.
de Chaffoy de Courcelles D; Roevens P; Wynants J; Van Belle H
Biochim Biophys Acta; 1987 Feb; 927(2):291-302. PubMed ID: 3028494
[TBL] [Abstract][Full Text] [Related]
8. An endogenous inhibitor of PAF-induced platelet aggregation, isolated from rat liver, has been identified as free fatty acid.
Siafaka-Kapadai A; Hanahan D
Biochim Biophys Acta; 1993 Feb; 1166(2-3):217-21. PubMed ID: 8382959
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-induced abnormal platelet activation in spontaneously hypertensive rats is linked with phosphoinositides turnover and phosphorylation of 47,000 and 20,000 dalton proteins.
Huzoor-Akbar ; Anwer K
Thromb Res; 1988 Jan; 49(1):5-21. PubMed ID: 2831638
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
11. Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.
Ishii H; Kuboki M; Fujii J; Hiraishi S; Kazama M
Thromb Res; 1990 Mar; 57(6):847-61. PubMed ID: 2382255
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
13. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation.
Vickers JD; Kinlough-Rathbone RL; Mustard JF
Biochem J; 1986 Jul; 237(2):327-32. PubMed ID: 3026316
[TBL] [Abstract][Full Text] [Related]
14. Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets.
Tysnes OB; Verhoeven AJ; Holmsen H
Biochem Biophys Res Commun; 1987 Apr; 144(1):454-62. PubMed ID: 3034251
[TBL] [Abstract][Full Text] [Related]
15. PCA-4248, a PAF receptor antagonist, inhibits PAF-induced phosphoinositide turnover.
Catalán RE; Martínez AM; Aragonés MD; Lombardía M; Garde E
Eur J Pharmacol; 1995 Aug; 290(3):183-8. PubMed ID: 7589212
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
[TBL] [Abstract][Full Text] [Related]
17. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
19. The aggregation of human platelet induced by ganodermic acid S.
Wang CN; Chen JC; Shiao MS; Wang CT
Biochim Biophys Acta; 1989 Nov; 986(1):151-60. PubMed ID: 2819092
[TBL] [Abstract][Full Text] [Related]
20. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets.
Ryningen A; Olav Jensen B; Holmsen H
Biochim Biophys Acta; 1998 Nov; 1394(2-3):235-48. PubMed ID: 9795233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
